DRUG NEWS: First parenteral antidote approved

April 2004 
Volume 34  Number 4
Pages 10 - 10
  PDF Version Available!

© 2004 Lippincott Williams & Wilkins, Inc. Volume 34(4)             April 2004             p 10 First parenteral antidote approved [DRUG NEWS: ACETAMINOPHEN TOXICITY]

The leading cause of drug toxicity in the United States, acetaminophen can destroy the liver when taken in large doses. The FDA has approved acetylcysteine (Acetadote Injection) to prevent or lessen liver damage from an acetaminophen overdose. The first I.V. treatment for acetaminophen overdose on the market, Acetadote is most effective when given within 8 to 10 hours of acetaminophen ingestion.

The most common adverse reactions to Acetadote are rash, urticaria, and pruritus. Some patients experience acute flushing and erythema of the skin; these reactions usually occur 30 to 60 minutes after the infusion starts and may resolve spontaneously even if the infusion continues.

Acetadote must be given cautiously in patients with ...

Purchase Now !

To purchase this item, follow the instructions below. If you’re not already logged in, be sure to enter your login information below to ensure that your item is saved to your File Drawer after you purchase it.

Not a member? Join now for Free!

1) If you're not already logged in, enter your information below to save this item in your File Drawer for future viewing.

User name:


Forgot your user name or password?
2)  If you have a coupon or promotional code, enter it
here.(If not, just click Continue.

Digital Coupon: (optional)

3)  Click Continue to go to the next screen, where
you'll enter your payment details.

jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles Recommended Nursing Articles Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events